(IBTM) iShares iBonds Dec 2032 - Ratings and Ratios
Treasury, Bonds, ETF, Maturity, 2032
Dividends
| Dividend Yield | 3.87% |
| Yield on Cost 5y | 4.12% |
| Yield CAGR 5y | 41.08% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 3.29% |
| Value at Risk 5%th | 5.43% |
| Relative Tail Risk | 0.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.83 |
| Alpha | 5.23 |
| CAGR/Max DD | 0.27 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.454 |
| Beta | -0.042 |
| Beta Downside | -0.083 |
| Drawdowns 3y | |
|---|---|
| Max DD | 10.28% |
| Mean DD | 2.84% |
| Median DD | 2.57% |
Description: IBTM iShares iBonds Dec 2032 December 31, 2025
The iShares iBonds Dec 2032 Term Treasury ETF (IBTM) tracks a market-value-weighted index of U.S. Treasury securities, net of holdings by the Federal Reserve’s System Open Market Account (SOMA). The fund is required to hold at least 80% of its assets in the index’s component securities and at least 90% in U.S. Treasuries that BFA deems appropriate for index tracking, except during the final months before the fund’s scheduled termination.
Key quantitative points to note: as of the latest data, IBTM’s weighted average maturity is approximately 10.5 years, delivering a current yield near 4.2%, which is sensitive to the Fed’s policy rate trajectory. The ETF’s expense ratio stands at 0.15%, modest relative to peers, and its average daily trading volume exceeds 200,000 shares, supporting liquidity. Macro-driven factors such as the U.S. Treasury yield curve steepening or flattening, and inflation expectations, directly influence the fund’s performance and total return.
For a deeper, data-rich analysis of IBTM’s risk-adjusted returns and scenario modeling, you might explore the ValueRay platform for additional insights.
What is the price of IBTM shares?
Over the past week, the price has changed by +0.07%, over one month by +0.48%, over three months by +0.91% and over the past year by +9.40%.
Is IBTM a buy, sell or hold?
What are the forecasts/targets for the IBTM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25 | 8.3% |
IBTM Fundamental Data Overview January 08, 2026
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 496.2m USD (496.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 496.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 496.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.76% (E(496.2m)/V(496.2m) * Re(5.76%) + (debt-free company))
Discount Rate = 5.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle